SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Thoracic Oncology Consultation — Yul Brynner

PatientYul Brynner
Date of birth1963-07-11
IdentifiersMRN HR-ML020-SYN; SSN (made up) 000-20-4572
Document date2026-09-15
AuthorLeah Morrow, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Left upper lobe mass invading the mediastinum with mediastinal nodes and left vocal fold paralysis in a 63-year-old former heavy smoker. Please establish the diagnosis and stage, direct biomarker testing, and advise on first-line treatment. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Mr. Brynner is seen at the request of Dr. Achterberg two weeks after he presented with six weeks of a weak, breathy voice. He is a stage actor and singer leading a touring production, which he has paused. He smoked about three packs a day from the age of 12 and quit 12 years ago. He has a mild morning cough, no hemoptysis, no chest, bone, or back pain, no headache, and no neurological symptoms, and his weight is steady after a small loss before presentation. He is fully active offstage but tires by evening. He has no autoimmune disease, organ transplant, or use of corticosteroids or other immunosuppressants. He wants the facts in full and wants to return to the stage. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Adenocarcinoma of the left upper lobe of the lung, stage IVB (cT4 N2 M1c, AJCC 8th edition), unresectable: the primary invades the mediastinum at the aortopulmonary window; bone metastases; PD-L1 tumor proportion score 70 percent (22C3); ECOG performance status 1; comprehensive genomic profiling results in the notesactiveconfirmed C34.12S — Synthetic modern histology, stage, and biomarkers linked to his documented inoperable lung cancer of September 1983.
Bone metastases at T10, the right ilium, and the left sixth rib on PET-CT, without pain, fracture, or cord compressionactiveconfirmed C79.51S — Synthetic metastatic sites chosen so that first-line systemic therapy is the standard of care; no source describes the spread of his cancer.
Left vocal fold paralysis with a breathy, weak voice, most likely from left recurrent laryngeal nerve involvement by disease in the aortopulmonary windowactiveconfirmed J38.01S — Synthetic laryngoscopy finding anchored to the published account that a vocal-cord problem led to his diagnosis; the lay 'lump on his vocal cords' is not modeled as a laryngeal tumor.
Left upper lobe mass invading the mediastinum, with enlarged mediastinal lymph nodes, on CT at presentation; suspicious for lung cancer pending tissue diagnosisactiveconfirmed R91.8S — Synthetic presenting imaging finding, recorded before the tissue diagnosis.
Former smoker: about 3 packs a day from age 12 until he quit 12 years ago, roughly 115 pack-years; no tobacco sinceactiveconfirmed Z87.891S — Synthetic modern entry linked to the documented heavy smoking and quitting; the pack-year figure is a synthetic midpoint of conflicting published amounts.

Physical Exam

Vital signs recorded on 2026-09-15; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralUpright and composed; ECOG 1; weight 72.0 kg
VoiceBreathy, low-volume voice
Lymph nodesNo supraclavicular or cervical nodes
LungsSlightly reduced breath sounds at the left apex
Spine and pelvisNo tenderness over T10, the ribs, or the right iliac crest
NeurologicalNormal strength, sensation, and gait

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-15Total score [Edmonton Symptom Assessment System]18{score}S

Assessment

Data reviewed: Laryngoscopy; CT of the chest, abdomen, and pelvis; FDG PET-CT and brain MRI eleven days ago; endobronchial ultrasound needle aspiration six days ago with cytology, immunohistochemistry, and PD-L1; plasma cell-free DNA sequencing; intake laboratory results. [S]

Plan of Treatment